AASPE is a laboratory under the dual supervision of the CNRS (INEE) and the National Museum of Natural History.
List of publications
, October 2021 — Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective. Human Gene Therapy. Vol. 32, 19-20, dir. Mary Ann Liebert, p. 1059-1075.
, July 2021 — Epigenetic rewriting at centromeric DNA repeats leads to increased chromatin accessibility and chromosomal instability. Epigenetics & Chromatin. Vol. 14, n° 1, dir. BioMed Central.
, December 2021 — « Tagging Proteins with Fluorescent Reporters Using the CRISPR/Cas9 System and Double-Stranded DNA Donors » in Multiprotein Complexes. P. 39-57.
, October 2021 — Unraveling Ewing Sarcoma Tumorigenesis Originating from Patient-Derived Mesenchymal Stem Cells. Cancer Research. Vol. 81, n° 19, dir. American Association for Cancer Research, p. 4994-5006.
, March 2021 — Correction of \beta-thalassemia by CRISPR/Cas9 editing of the \alpha-globin locus in human hematopoietic stem cells. Blood Advances. Vol. 5, n° 5, dir. The American Society of Hematology, p. 1137-1153.
, February 2021 — Precise base editing for the in vivo study of developmental signaling and human pathologies in zebrafish. eLife. Vol. 10, dir. eLife Sciences Publication.
, July 2020 — Characterization of post-edited cells modified in the TFAM gene by CRISPR/Cas9 technology in the bovine model. PLoS ONE. Vol. 15, n° 7, dir. Public Library of Science, e0235856.
, January 2020 — Heat Shock Factor 2 Protects against Proteotoxicity by Maintaining Cell-Cell Adhesion. Cell Reports. Vol. 30, n° 2, dir. Elsevier Inc, 583-597.e6.
, February 2020 — Expression analysis data of BCL11A and \gamma-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion. Data in Brief. Vol. 28, dir. Elsevier, p. 104974.
, 2020 — AP-TSS: A New Method for the Analysis of RNA Expression from Particular and Challenging Transcription Start Sites. Biomolecules. Vol. 10, n° 6, dir. MDPI, p. 827.
, July 2020 — Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nature Communications. Vol. 11, n° 1, dir. Nature Publishing Group, p. 3778.
, February 2020 — Editing a y-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype. Science Advances. Vol. 6, n° 7, dir. American Association for the Advancement of Science (AAAS), eaay9392.
, December 2019 — A novel lineage of candidate pheromone receptors for sex communication in moths. eLife. Vol. 8, dir. eLife Sciences Publication.
, March 2019 — Edition of TFAM gene by CRISPR/Cas9 technology in bovine model. PLoS ONE. Vol. 14, n° 3, dir. Public Library of Science, e0213376.
, November 2019 — Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-Generated by Crispr-Cas9. Animal Model Exp Med / Animal models and experimental medicine. Vol. 2, n° 4, dir. [Hoboken, New Jersey] : John Wiley \& Sons, Inc., [2018]-, p. 297-311.
, 2019 — Differential Requirements for the RAD51 Paralogs in Genome Repair and Maintenance in Human Cells. PLoS Genetics. Vol. 15, n° 10, dir. Public Library of Science, e1008355.
, February 2019 — Investigating the Effect of Mono- and Dimeric 360A G-Quadruplex Ligands on Telomere Stability by Single Telomere Length Analysis (STELA). Molecules. Vol. 24, n° 3, dir. MDPI, p. 577.
, July 2019 — Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease. European Journal of Pharmacology. Vol. 854, dir. Elsevier, p. 398-405.
, February 2019 — UCP1 transrepression in Brown Fat in vivo and mineralocorticoid receptor anti-thermogenic effects. Annales d’Endocrinologie. Vol. 80, n° 1, dir. Elsevier Masson, p. 1-9.
, June 2019 — Repression of TERRA Expression by Subtelomeric DNA Methylation Is Dependent on NRF1 Binding. International Journal of Molecular Sciences. Vol. 20, n° 11, dir. MDPI, p. 2791.